Sector: health
Conviction from: S&P
52-week range: 163.11462.87
A US health-insurance company focused on Medicare Advantage and government-sponsored health plans, and offering integrated care and pharmacy services.
7 tracked filer(s) hold this · 1 opened, 4 added, 1 trimmed in 30-SEP-2026
Aggregate 13FScore 60 — mean of 7 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Stanley Druckenmiller / Duquesne | 91 | New buy | 65,220 | $24,886 | 0.6% |
| Larry Robbins / Glenview | 61 | Added +120% | 560,085 | $213,711,633 | 3.5% |
| George Soros / Soros Fund Mgmt | 33 | Added +23% | 40,990 | $15,640,554 | 0.2% |
| Steve Cohen / Point72 | 75 | Added +74% | 222,513 | $84,904,285 | 0.1% |
| Bridgewater | 55 | Added +52% | 13,908 | $5,306,876 | 0.0% |
| Ancora | 42 | Holds (flat) | 245 | $93,485 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -19% | 87,011 | $33,200,787 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
11 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-09-22 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,004 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $100,001 - $250,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| Report | Date | Stance |
|---|
| #80 — Market Memo: January Musings | 2025-01-09 | WATCH |